The risk of infection with new oral anticoagulants: a meta-analysis

Int J Cardiol. 2014 Mar 1;172(1):267-8. doi: 10.1016/j.ijcard.2013.12.248. Epub 2014 Jan 10.

¹ Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal; Laboratory of Clinical Pharmacology, Faculty of Medicine, University of Lisbon, Portugal. Electronic address: dgcaldeira@hotmail.com.
² Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal; Laboratory of Clinical Pharmacology, Faculty of Medicine, University of Lisbon, Portugal; Portuguese Collaborating Centre of the Cochrane Iberoamerican Network, Faculty of Medicine, University of Lisbon, Portugal.
³ Cardiology Department, CCUL, CAML, Faculty of Medicine, Lisbon, Portugal.
⁴ Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal; Laboratory of Clinical Pharmacology, Faculty of Medicine, University of Lisbon, Portugal.

No abstract available

Keywords: Apixaban; Dabigatran; Infection; Meta-analysis; Rivaroxaban; Urinary tract infection.

Publication types